Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: 165.6B DKK
Have any thoughts about
Novozymes A/S?
Write Note

Gross Margin
Novozymes A/S

54.3%
Current
56%
Average
23.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
54.3%
=
Gross Profit
9.7B
/
Revenue
17.9B

Gross Margin Across Competitors

Country DK
Market Cap 165.6B DKK
Gross Margin
54%
Country US
Market Cap 86.5B USD
Gross Margin
48%
Country US
Market Cap 68B USD
Gross Margin
43%
Country JP
Market Cap 10.2T JPY
Gross Margin
38%
Country CH
Market Cap 36.4B CHF
Gross Margin
43%
Country CN
Market Cap 235.1B CNY
Gross Margin
15%
Country US
Market Cap 32.1B USD
Gross Margin
36%
Country US
Market Cap 27.8B USD
Gross Margin
42%
Country CH
Market Cap 25.9B EUR
Gross Margin
25%
Country IN
Market Cap 2.2T INR
Gross Margin
43%
Country US
Market Cap 21.7B USD
Gross Margin
35%
No Stocks Found

Novozymes A/S
Glance View

Market Cap
165.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NZYM B Intrinsic Value
124.53 DKK
Overvaluation 69%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
54.3%
=
Gross Profit
9.7B
/
Revenue
17.9B
What is the Gross Margin of Novozymes A/S?

Based on Novozymes A/S's most recent financial statements, the company has Gross Margin of 54.3%.